Financials data is unavailable for this security.
View more
Year on year Jaguar Health Inc has grown net income from a loss of -47.45m to a smaller loss of -41.30m despite falling revenues.
Gross margin | 80.10% |
---|---|
Net profit margin | -365.71% |
Operating margin | -276.58% |
Return on assets | -73.81% |
---|---|
Return on equity | -504.20% |
Return on investment | -106.50% |
More ▼
Cash flow in USDView more
In 2023, Jaguar Health Inc increased its cash reserves by 18.28%, or 1.00m. Cash Flow from Financing totalled 34.23m or 350.65% of revenues. In addition the company used 33.24m for operations while cash from investing was breakeven.
Cash flow per share | -9.59 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.54 |
---|---|
Tangible book value per share | -0.2736 |
More ▼
Balance sheet in USDView more
Current ratio | 1.84 |
---|---|
Quick ratio | 1.36 |
Total debt/total equity | 2.06 |
---|---|
Total debt/total capital | 0.6802 |
More ▼